Product Information
PERCOCET 7.5-325 MG TABLET is a brand (anda) product labeled by Endo USA Inc., priced at $31.6048 per EA under NDC 63481062870. Its NADAC has been published 588 times since Nov 28, 2013.
FDA first approved this application on Jun 25, 1999. Its Orange Book therapeutic-equivalence code is AA.
Strength
325; 7.5 mg/1; mg/1
Manufacturer
Endo USA Inc.NDC
63481062870
Classification
Brand (ANDA)
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ACETAMINOPHEN; OXYCODONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA040330FDA Approved
6/25/1999
TE Code
AA
On Market Since
11/30/2001
Pharmacological Classes
Price Statistics
The NADAC for PERCOCET 7.5-325 MG TABLET has been published 588 times since Nov 28, 2013, and over the history we have for it it has risen 459.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $31.6048 per EA |
|---|---|
| All-time high | $31.8078 (Dec 10, 2025) |
| All-time low | $5.6520 (Nov 28, 2013) |
| 52-week high | $31.8078 |
| 52-week low | $31.6048 |
| Median price | $20.8121 |
| Average price | $19.1392 |
| Largest weekly change | +43.7% (Feb 19, 2020) |
| Weeks tracked | 588 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 99% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Endo USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
oxycodone hydrochloride and acetaminophen market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Opioid Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PERCOCET 7.5-325 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PERCOCET 7.5-325 MG TABLET, manufactured by Endo USA Inc., is $31.6048 per EA (NDC 63481062870), effective Sep 30, 2026.
How has the price of PERCOCET 7.5-325 MG TABLET changed over time?
Over the history we have for it, the NADAC for PERCOCET 7.5-325 MG TABLET has risen 459.2%. It has been tracked across 588 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for PERCOCET 7.5-325 MG TABLET?
Since Nov 28, 2013, the NADAC for PERCOCET 7.5-325 MG TABLET has ranged from a low of $5.6520 (Nov 28, 2013) to a high of $31.8078 (Dec 10, 2025), with a median of $20.8121 per EA.
Are there cheaper alternatives to PERCOCET 7.5-325 MG TABLET?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, OXYCODONE-ACETAMINOPHEN 7.5-325 MG TABLET, is $0.1825 per EA — about 99% below PERCOCET 7.5-325 MG TABLET.
Who manufactures PERCOCET 7.5-325 MG TABLET?
PERCOCET 7.5-325 MG TABLET (NDC 63481062870) is labeled by Endo USA Inc., and CMS classifies it as a brand (anda) product.